This study is recruiting. It focuses on depression and currently lists participation information in France.
This study is looking at estimate, from a collective point of view, the incremental cost-utility ratio of VNS to treat patients suffering from RD for people with Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments. Taking part may give some people access to a digital support tool with regular follow-up, but direct benefit is not guaranteed.
The official record suggests in-person participation through a hospital, with sites including CHU Angers, Centre Hospitalier Charles Perrens in Bordeaux, and CHU Caen. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis and being able to follow the planned visits or tasks, while common reasons not to take part include pregnancy or breastfeeding and active substance or alcohol problems that could affect the results. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordThis form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Taking part may give access to a new approach being evaluated.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in France.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring digital app or tool for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Assistance Publique - Hôpitaux de Paris. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
This study may involve digital app or tool, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.